Publications

CARDIOLOGY

Robert J. Gil, Tomasz Pawlowski & Jacek Bil

Feasibility and safety of the new coronary non-compliant balloon catheter River NC®

READ

CARDIOLOGY

Jacek Bil, Paweł Modzelewski, Agnieszka Pawlak, Robert J Gil
DEPARTMENT OF INVASIVE CARDIOLOGY, CENTRE OF POSTGRADUATE MEDICAL EDUCATION, POLAND

Balloon aortic valvuloplasty with Valver® balloon catheter in adults with severe aortic stenosis as a bridge or palliative treatment.

READ

CARDIOLOGY

Pawel Gasior, Shengjie Lu, Chen Koon Jaryl Ng, Wee Yee Daniel Toong, En Hou Philip Wong, Nicolas Foin, Elvin Kedhi, Wojciech Wojakowski & Hui Ying Ang

Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents.

READ

CARDIOLOGY

Robert J. Gil, Adam Kern, Radoslaw Formuszewicz, Luis A. Inigo Garcia, Slawomir Dobrzycki, Dobrin Vassilev, Jacek Bil

6-year results of BiOSS stents in coronary bifurcation treatment.

READ

Phlebology

Marek Iłżecki, Piotr Terlecki, Stanisław Przywara, Tomasz Zubilewicz
Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland
Phlebological Review 2021; 29, 1: 32–37

Single-centre experience with mechanochemical ablation of insufficient veins with the Flebogrif® catheter in a 36-month follow-up.

Read

Phlebology

Tamana Alozai, Eline Huizing, Michiel Schreve, Michael C Mooij, Clarissa J van Vlijmen, Willem Wisselink, Cagdas Unlu Affiliations
PMID: 34091106

A systematic review and meta-analysis of mechanochemical endovenous ablation using FlebogrifR for varicose veins: A summary of evidence.

Read

Phlebology

Zbigniew Rybak, Maciej Janeczek, Maciej Dobrzynski, Marta Wujczyk, Albert Czerski, Piotr Kuropka, Agnieszka Noszczyk-Nowak, Maria Szymonowicz, Aleksandra Sender-Janeczek, Katarzyna Wiglusz , Rafal J Wiglusz
PMID: 33669987, PMCID: PMC7924836

Study of Flebogrif® – A New Tool for Mechanical Sclerotherapy-Effectiveness Assessment Based on Animal Model

Read

CARDIOLOGY

Magdalena Dobrolińska, Paweł Gąsior, Tomasz Roleder, Magda Roleder-Dylewska, Grzegorz Smolka, Andrzej Ochała, Elvin Kedhi, Wojciech Wojakowski

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

READ

Phlebology

Marek Iłżecki, Piotr Terlecki, Stanisław Przywara, Joanna Iłżecka, Tomasz Zubilewicz

The novel minimally invasive mechano-chemical technique of the saphenous vein ablation. Our center experience: results of 24 months follow-up

Read

Phlebology

Piotr Ciostek, Marcin Kowalski, Witold Woźniak, Tomasz Miłek, Piotr Myrcha, Bartosz Migda

Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study

Read

Phlebology

Marek Iłżecki, Piotr Terlecki, Stanisław Przywara, Tomasz Urbanek, Agnieszka Pedrycz-Wieczorska, Shawn Dave, Tomasz Zubilewicz

A NEW DEVICE FOR MINIMALLY INVASIVE MECHANO-CHEMICAL METHOD OF SAPHENOUS VEIN ABLATION. REPORT OF 12 MONTHS OF FOLLOW UP

Read

Phlebology

Tomasz Zubilewicz, Piotr Terlecki, Karol Terlecki, Stanislaw Przywara, Janusz Rybak, Marek Ilzecki

APPLICATION OF ENDOVENOUS MECHANOCHEMICAL ABLATION (MOCA) WITH FLEBOGRIFTM TO TREAT VARICOSE VEINS OF THE LOWER EXTREMITIES: A SINGLE CENTER EXPERIENCE OVER 3 MONTHS OF OBSERVATION

Read

Cardiology

Luis A. Iñigo-Garcia, Rafael Bravo-Moarues, Leticia Fernandez-Lopez, Francisco J. Martinez-Garcia, Juan R. Siles-Rubio, Antonio Ramirez-Moreno, Francisco Ruiz-Mateas, Tomas Urda-Valcarel

TRATAMIENTO DE LAS LESIONES EN BIFURCACIÓN MEDIANTE EL STENT DEDICADO BIOSS: RESULTADOS CLÍNICOS Y ANGIOGRÁFICOS AL AÑO

View

Cardiology

Luis A. Iñigo-Garcia, Rafael Bravo-Moarues, Leticia Fernandez-Lopez, Francisco J. Martinez-Garcia, Juan R. Siles-Rubio, Antonio Ramirez-Moreno, Francisco Ruiz-Mateas, Tomas Urda-Valcarel

Resultados a largo plazo del tratamiento con stent farmacoactivo con polimero biodegradable vs polimero bioestable

View

Cardiology

Robert J. Gil, M.D., Ph .D., F.E.S.C., Jacek Bil, M.D., Ph .D, Dobrin Vassiliev, M.D., Ph .D, and Luis a. Iñigo Garcia, M.D.
First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent: 12-Month Results of BiOSS LIM® Registry
© 2015, Wiley Periodicals, Inc. DOI: 10.1111/joic.12180
View

Radiology

Kazimierz Kordecki, Adam Łukasiewicz, Mirosław Nowicki, Andrzej Lewszuk, Radosław Kowalewski, Bogusław Panek, Michał Zawadzki, Paweł Michalak, Marek Gacko, Urszula Łebkowska

Assessment of effectiveness of endovascular treatment of common and external iliac artery stenosis/occlusion using self-expanding Jaguar SM stents

View

Cardiology

Piotr P. Buszman, MD, PhD, Krzysztof Milewski, MD, PhD, Aleksander Żurakowski, MD, PhD, Jacek Pajak, MD, PhD, Michał Jelonek, MD, Paweł Gasior, Athanasios Peppas, MS, Armando Tellez, MD, Juan F. Granada, MD, and Paweł E. Buszman, MD, PhD

Experimental Evaluation of Pharmacokinetic Profile and Biological Effect of a Novel Paclitaxel Microcrystalline Balloon Coating in the Iliofemoral Territory of Swine.

View

Cardiology

Piotr P. Buszman, MD, PhD; Krzysztof Milewski, MD, PhD; Jacek Pająk, MD, PhD; Michał Jelonek, MD; Bartłomiej Orlik, MD; Agata Krauze, MS; Beata Gwiazdowska-Nowotka, MS; Wojciech Wojakowski, MD, PhD; Armando Tellez, MD; Juan F. Granada, MD; Paweł E. Buszman MD, PhD

Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.

View

Cardiology

Jacek Legutko, Robert J Gil, Pawel E Buszman, Greg L Kaluza, Marek Krol, Roman Wojdyla, Tomasz Pawlowski, Michal Brzezinski, Marek Kondys, Bartosz Skwarna, Jacek Jakala, Tomasz Roleder, Wojciech Zasada, Dariusz Dudek

OCT evaluati on of the ti me course of vessel healing following implantati on of new generati on biodegradable polymer-coated and sirolimus-eluti ng cobalt-chromium coronary stent system (ALEX OCT Study).

View

Cardiology

Martinez-Garcia, Francisco J.; Iñigo-Garcia, Luis A.; Sanz-Vazquez O.; Pombo-Jimenez M.; Muñoz Bellido Juan F.; Fernández-López L.; Gil-Jimenez T.; Ruiz-Mateas, F. Hospital Costa del Sol. Marbella.

LONG TERM RESULTS OF PERCUTANEOUS CORONARY TREATMENT: DEDICATED STENT VS REGULAR DES TREATMENT.

View

Cardiology

Robert J. Gil, Dobrin Vassilev, Jacek Bil, Luis A. Iñigo Garcia

First-in-man study of dedicated bifurcation sirolimus eluting stent – interim analysis of BiOSS LIM Registry.

View

Cardiology

Robert J. Gil, Dobrin Vassilev, Jacek Bil, Adam Kern, Radoslaw Formuszewicz, Sławomir Dobrzycki

Regular drug eluting stent versus dedicated bifurcation paclitaxel-eluting stent in coronary bifurcation treatment (POLBOS study) – interim analysis.

View

Cardiology

Robert J. Gil, Jacek Bil, Aleksandra Michałek,Dobrin Vassiliev, Ricardo A. Costa
Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS® stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study.
© The Author(s) 201310.1007/s10554-013-0264-0
View

Cardiology

Buszman PP, Orlik B, Trela B, Milewski K, Kozłowski M, Pruski M Jr, Drzewiecki J, Peppas A, Granada JF, Kaluza GL, MD PE
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: Insights from a multicenter, propensity score-matched registry.
Catheter Cardiovasc. Interv. 2012 Oct 29. doi: 10.1002/ccd.24732.
View

Cardiology

Milewski K, Gorycki B, Buszman PP, Jelonek M, Beaudry D, Lapointe JM, Guy LG, Abusamra M, Pająk J, Kinasz W, Wojakowski W, Leclerc G, Gil R, Buszman PE.
Odpowiedź naczyniowa i integralność mechaniczna nowego stentu PROLIM pokrytego polimerem uwalniającym sirolimus po jego wszczepieniu do tętnic wieńcowych świni.
Vascular Response and Mechanical Integrity of the New Biodegradable Polymer Coated Sirolimus Eluting PROLIM Stent Implanted in Porcine Coronary Arteries.
Kardiol Pol. 2012;70(7):703-11.
View

Cardiology

Gil RJ, Vassiliev D, Michałek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A.
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population.
EuroIntervention 2012 Jul 20;8(3):316-24
View

Cardiology

Gil RJ, Vassiliev D, Michałek A, Kern A, Formuszewicz R, Dobrzycki S, Lesiak M, Wójcik J, Kardaszewicz P, Lekston A.
Rejestr stentu uwalniającego paklitaksel dedykowanego zwężonym bifurkacjom wieńcowym (BiOSS): wyniki 3−miesięczne.
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
Kardiol Pol. 2012 ;70(1):45-52
View

Cardiology

Vassilev D, Gil R, Milewski K.
Bifurcation Optimization Stent System (BiOSS Lim) with sirolimus elution – results from porcine coronary artery model.
EuroIntervention. 2011 Sep;7(5):614-20.
View

Cardiology

Gil RJ, Vassiliev D, Michałek A, Kern A, Formuszewicz R, Dobrzycki S, Lesiak M, Wójcik J, Kardaszewicz P, Lekston A.
Rejestr stentu uwalniającego paklitaksel dedykowanego zwężonym bifurkacjom wieńcowym (BiOSS): wyniki 3−miesięczne.
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
Kardiol Pol. 2012 ;70(1):45-52
View

Cardiology

Vassilev D, Gil R, Milewski K.
Bifurcation Optimization Stent System (BiOSS Lim) with sirolimus elution – results from porcine coronary artery model.
EuroIntervention. 2011 Sep;7(5):614-20.
View

Cardiology

Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G.
Nowy stent pokryty biodegradowalnym polimerem, uwalniający paklitaksel, hamuje przerost neointimy w tętnicach wieńcowych świni.
Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Kardiol Pol. 2010 May;68(5):503-9
View

Cardiology

Buszman PE, Milewski K.
Stenty LUC-Chopin2 pokryte polimerem biodegradowalnym uwalniającym paklitaksel. LUC-Chopin2 – biodegradable polymer-coated, paclitaxel-eluting stent.
Inż.Biomed. / Acta Bio-Optica Inform.Med.2007; Vol.13 nr 3, s.200.

Cardiology

Buszman P, Trznadel S, Zurakowski A, Milewski K, Kinasz L, Król M, Kondys M.
Prospektywny rejestr oceniający skuteczność i bezpieczeństwo leczenia chorych ze zmianami de novo w naczyniach wieńcowych przy użyciu stentów kobaltowo-chromowych.

Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
Kardiol Pol. 2007 Sep;65(9):1041-6
View

Cardiology

P. Buszman, K. Milewski, S. Trznadel, J. Rzeźniczak, T. Przewłocki, M. Kośmider, J. Wójcik, J. Janczak, L. Kinasz, M. Kondys, M. Król, A. Żurakowski, R. Gil.
Complete 12 months clinical results of a prospective multicentre registry for the assessment of safety and efficacy of biodegradable polymer-coated, paclitaxel-eluting stent – LUC-Chopin2 (BALTON, POLAND).
Kardiol.Pol.2007; T.65 (8) supl.3, s.S169-S170, [P001]. 11 Międzynarodowy Kongres Polskiego Towarzystwa Kardiologicznego, Wrocław 20-22.09.2007

Cardiology

Buszman P, Zurakowski A, Kinasz L, Gorycki B, Krol M, Lewicki A, Flak Z, Milewski K, Zurek P.
Polski stent Chopin. Ocena skuteczności leczenia zmian de-novo w naczyniach wieńcowych metodą przezskórnej angioplastyki.
The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
Kardiol Pol 2005;62: 451-456.
View

Call: (+48) 22 597-44-00 or send an e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Office

Balton Sp. z o.o.
00-496 Warsaw
7/14 Nowy Świat Str.
tel.: (+48) 22 625 32 15
tel./fax: (+48) 22 621 58 14

Production Site

03-152 Warsaw
294 Modlińska Str.
tel.: (+48) 22 597 44 00
fax: (+48) 22 597 44 44
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Personal Data Protection under the General Data Protection Regulation (GDPR) at Balton Sp. z o. o.

Copyright © Balton Sp. z o. o. 2022

Projekt i wykonanie: